Suggestions
Lionel Leventhal
Managing Director and Head, Royalty & Revenue Interest Financing at Ladenburg Thalmann
Lionel Leventhal is a finance expert, entrepreneur, and philanthropist who serves as a Board Member at ART MEDICAL Ltd.1 He has a diverse range of interests and expertise in the healthcare and business sectors.
Professional Background
Leventhal specializes in helping to finance pharmaceutical, biotech, medical device, and diagnostic companies.1 His expertise lies in providing non-dilutive revenue financing solutions to businesses in these industries.
Education
Lionel Leventhal is an alumnus of Harvard Business School. He recently reflected on his 25th reunion, indicating his long-standing connection with the institution.3
Recent Activities
Healthcare Involvement:: Leventhal has shown a keen interest in various medical conditions and treatments. In 2022, he shared information about swallow therapy in relation to a friend diagnosed with Adenoid Cystic Carcinoma (ACC), demonstrating his engagement with healthcare issues.5
Civic Engagement:: He is actively involved in local politics, having participated in the NYC mayoral primary in 2024.2
Networking and Philanthropy:: Leventhal is known for his networking efforts and willingness to help others. He has been involved in "pay it forward" initiatives, offering assistance and networking opportunities to professionals in his network.4
Personal Interests
Outside of his professional life, Lionel Leventhal takes pride in his family. He has mentioned his brother Alex, who is recognized as one of the top 20 MBA admissions consultants worldwide.6
Lionel Leventhal's LinkedIn profile (username: lionelleventhal) serves as a platform for him to share his thoughts on business, healthcare, and personal experiences, reflecting his multifaceted career and interests.
Highlights
To those of you I have been mentoring for internships, first jobs after graduating from college and business school and job pivots, be tenacious and don’t get discouraged, research the company and industry thoroughly in advance and know your audience:
If you are interested in learning more about Royalty/Revenue Interest Financing (RIF) as a source of low-cost, non-dilutive financing to fund: commercial or late-stage biopharma/medical device/diagnostics companies, or commercial stage SaSS software companies, franchisor/franchise model businesses, other subscription-based or utility-like businesses with sticky customer relationships or other royalty/license-based businesses (e.g. music or other entertainment libraries, licensed merchandise, oil & gas, etc.) please watch my recent presentation at Marty S.'s IVYFON family office conference in NYC.
